Dianthus Therapeutics | MGTA - Market Capitalization


Dianthus Therapeutics reported $2.52B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alaunos Therapeutics USD 6M 1000K Jun/2026
Avita Medical AUD 127.11M 21.64M Jun/2026
Celltrion KRW 1.81T 620B Jun/2026
Cspc Pharmaceutical CNY 103.79B 16.5B Mar/2026
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 2.46B 2.87B Nov/2026
Divis Laboratories Ltd INR 3.07T 598.82B Nov/2026
IQVIA Holdings USD 48.06B 3.81B Nov/2026
Kangmei Pharma CNY 16.59B 7.89B Jun/2026
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
Malin Corporation EUR 133.52M 29.05M Aug/2026
Medical Developments International AUD 62.53M 563.29K Dec/2025
Moderna USD 99.14B 22.26B Nov/2026
Neuren Pharmaceuticals AUD 2.36B 606.56M Dec/2025
Organigram Holdings CAD 128.48M 74.94M Nov/2026
Organon & Co USD 3.55B 54.3M Nov/2026
Ovoca Bio EUR 1.17M 18.38K Dec/2025
Pharma Mar EUR 1.17B 85.18M Nov/2026
Qiagen NV USD 10.01B 2.04B Nov/2026
Revvity USD 19.52B 2.61B Nov/2026
Sartorius EUR 17.42B 1.8B Sep/2026
Tectonic Therapeutic USD 649M 69M Jun/2026
Viatris USD 22.53B 2.18B Nov/2026
Xeris Pharmaceuticals USD 1.44B 70M Nov/2026
Zealand Pharma A/S 20.84B 12.51B Mar/2026
Zz Pientze Pharmaceu CNY 76.62B 5.43B Nov/2026